SEngine Precision Medicine Partners with Vincere Cancer Center to Increase Access for First Responders to Get Personalized Cancer Treatments via the PARIS® Test
SEATTLE, Sept. 07, 2022 (GLOBE NEWSWIRE) — Seattle-based Precision Oncology company SEngine Precision Medicine and…